Abstract:
LEN is given as a 927 mg subcutaneous
injection every six months. Patients
must be confirmed HIV-negative before
the first and each subsequent dose. The
injection is administered by a trained
health professional under aseptic
conditions. Because the drug persists in
the body for a long time, missed or
delayed doses may increase the risk of
HIV infection and resistance, making
timely administration essential.
